Jonathan Peacock
2015
In 2015, Jonathan Peacock earned a total compensation of $1.2M as former Chief Executive Officer at Bellerophon Therapeutics, a 76% decrease compared to previous year.
Compensation breakdown
Bonus | $400,000 |
---|---|
Option Awards | $356,534 |
Salary | $400,000 |
Stock Awards | $13,278 |
Other | $11,215 |
Total | $1,181,027 |
Peacock received $400K in bonus, accounting for 34% of the total pay in 2015.
Peacock also received $356.5K in option awards, $400K in salary, $13.3K in stock awards and $11.2K in other compensation.
Rankings
In 2015, Jonathan Peacock's compensation ranked 7,125th out of 13,638 executives tracked by ExecPay. In other words, Peacock earned more than 47.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,125 out of 13,638 | 48th |
Division Manufacturing | 2,688 out of 5,190 | 48th |
Major group Chemicals And Allied Products | 967 out of 1,854 | 48th |
Industry group Drugs | 776 out of 1,528 | 49th |
Industry Pharmaceutical Preparations | 605 out of 1,182 | 49th |
Source: SEC filing on March 20, 2017.
Peacock's colleagues
We found five more compensation records of executives who worked with Jonathan Peacock at Bellerophon Therapeutics in 2015.
2015
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
2015
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
2015
Reinilde Heyrman
Bellerophon Therapeutics
former Chief Clinical Development Officer
2015
Martin Dekker
Bellerophon Therapeutics
Vice President of Device Engineering and Manufacturing
2015
Peter Fernandes
Bellerophon Therapeutics